These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26257598)

  • 1. Antidepressant mechanism of ketamine: perspective from preclinical studies.
    Scheuing L; Chiu CT; Liao HM; Chuang DM
    Front Neurosci; 2015; 9():249. PubMed ID: 26257598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
    Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
    Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of ketamine action as an antidepressant.
    Zanos P; Gould TD
    Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
    Niciu MJ; Henter ID; Luckenbaugh DA; Zarate CA; Charney DS
    Annu Rev Pharmacol Toxicol; 2014; 54():119-39. PubMed ID: 24392693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.
    Iadarola ND; Niciu MJ; Richards EM; Vande Voort JL; Ballard ED; Lundin NB; Nugent AC; Machado-Vieira R; Zarate CA
    Ther Adv Chronic Dis; 2015 May; 6(3):97-114. PubMed ID: 25954495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
    Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA
    Neural Plast; 2015; 2015():858251. PubMed ID: 26137324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine Exhibits Different Neuroanatomical Profile After Mammalian Target of Rapamycin Inhibition in the Prefrontal Cortex: the Role of Inflammation and Oxidative Stress.
    Abelaira HM; Réus GZ; Ignácio ZM; Dos Santos MAB; de Moura AB; Matos D; Demo JP; da Silva JBI; Danielski LG; Petronilho F; Carvalho AF; Quevedo J
    Mol Neurobiol; 2017 Sep; 54(7):5335-5346. PubMed ID: 27590136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression.
    Price JB; Yates CG; Morath BA; Van De Wakker SK; Yates NJ; Butters K; Frye MA; McGee SL; Tye SJ
    Transl Psychiatry; 2021 Nov; 11(1):598. PubMed ID: 34824208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt mediates GSK-3β phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions.
    Zhou W; Dong L; Wang N; Shi JY; Yang JJ; Zuo ZY; Zhou ZQ
    Neuroimmunomodulation; 2014; 21(4):183-8. PubMed ID: 24504086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine's Antidepressant Action.
    Aleksandrova LR; Wang YT; Phillips AG
    Chronic Stress (Thousand Oaks); 2017; 1():. PubMed ID: 30556028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multiscale View of the Mechanisms Underlying Ketamine's Antidepressant Effects: An Update on Neuronal Calcium Signaling.
    Kawatake-Kuno A; Murai T; Uchida S
    Front Behav Neurosci; 2021; 15():749180. PubMed ID: 34658809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
    Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
    Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in sub-anesthetic ketamine's antidepressant effects and abuse liability.
    Wright KN; Kabbaj M
    Curr Opin Behav Sci; 2018 Oct; 23():36-41. PubMed ID: 30038955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.
    Costemale-Lacoste JF; Guilloux JP; Gaillard R
    Encephale; 2016 Apr; 42(2):156-64. PubMed ID: 26995153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine.
    Hashimoto K
    Expert Rev Neurother; 2011 Jan; 11(1):33-6. PubMed ID: 21158553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.